West Pharmaceutical showcases injectable packaging advancements at 2022 PDA Annual Meeting April 4-6 in Dallas, Texas; topics include Naloxone closed-loop wearable injector system, prefilled syringe interactions with therapeutic proteins

Sample article from our Health Care Sector

EXTON, Pennsylvania , April 4, 2022 (press release) –

  • West to moderate sessions, give keynote presentation, and share scientific posters, highlighting expertise in ensuring quality, sterility and stability of injectable drug products

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its participation at the 2022 PDA Annual meeting to include sharing the latest in packaging science with scientific talks, moderating session panels and presenting posters, throughout the meeting.

"With ever evolving patient needs and changing healthcare landscape, West remains on the forefront of packaging science by helping our customers address new demands and needs," said Cindy Reiss-Clark, Senior Vice President, Global Market Units and Commercial Solutions at West. "Through these presentations, posters and panels at the 2022 PDA Annual Meeting, we are sharing the cutting edge of packaging technology and knowledge that helps our customers speed their development of important therapies and drive better patient outcomes."

Featured Speaking Sessions:
Title: Development of a Closed-Loop Wearable Injector System for Emergency Delivery of Naloxone
Speaker: Alexander Lyness, Ph.D., Senior Manager, Research & Technology
Session: Manufacturing Science, C3: Responding to Patient Needs
Date and time: April 6 at 10:45 a.m. CDT

Featured Poster Sessions:
Title: Experimental and Theoretical Evaluation of Vial Container Closure System Components Using the DeltaCubeā„¢ Modeling Platform
Author: Anthony Bucci, Principal Research Engineer

Title: Understanding the interactions of prefilled syringes with therapeutic proteins at low concentrations
Authors: Leo Breydo, Senior Scientist

Title: Utilizing Interfacial Tension to Reduce Prefilled Syringe Functionality Risks
Author: Liang Fang, Technical Director/Fellow Scientist and Marissa Rase, Associate Scientist

Moderated Panels:
Session: Enter Player 2
Speaker: Diane Paskiet, Director, Scientific Affairs
Date and time: April 4 at 3:30 p.m. CDT

Session: Interest Group, IG5: Packaging Science
Speaker: Susan Dounce, Ph.D., Director of Commercial Technology Development
Date and time: April 6 at 8:30 a.m. CDT

Session: Manufacturing Science
Speaker: Diane Paskiet, Director, Scientific Affairs
Date and time: April 6 at 10:45 a.m. CDT

For more information about West, please visit our website: www.westpharma.com.

For more information about the 2022 PDA Annual Meeting, please visit: https://www.pda.org/global-event-calendar/event-detail/2022-pda-annual-meeting.

About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With approximately 10,000 team members across 50 sites worldwide, West helps support our customers by delivering over 45 billion components and devices each year. 

Headquartered in Exton, Pennsylvania, and in business for nearly a century, West in its fiscal year 2021 generated $2.83 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.

SOURCE West Pharmaceutical Services, Inc.

Primary Media Contact: Cynthia Salitsky, Director, External Global Communications, +1-484-983-4893, Cynthia.Salitsky@westpharma.com; Secondary Media Contact: Michele Polinsky, Vice President, Global Communications, +1-610-594-3054, Michele.Polinsky@westpharma.com

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Dan Rivard
Dan Rivard
- VP Market Development -

We offer built-to-order health care sector coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.